BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
VIP Nasal, toote foto
Immune System

VIP Nasal

Immune System

  • Saadetakse Saksamaalt

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

Otsitud ka nimega: VIP Nasenspray

Lühidalt

VIP Nasal arvudes

Põhinäitajad meie leksikonist.

Täielik leksikoni artikkel
Class
Neuropeptide of 28 amino acidsimmune-regulating and vasodilating
Half-life
About 1 minute in bloodmeasured after intravenous infusion
Frequency
Dailyeach dose acts only briefly
Form
Ready-made nasal spray, 10mg in 5.4ml1.85mg/ml, about 185mcg per spray
Sizes
10 mg1 size in the shop

Teadmised

Kõik teemal VIP Nasal

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

Is VIP approved?

Not as a single drug. ChEMBL lists synthetic VIP (aviptadil) at phase 3, the large trials ran in COVID-19. According to a review a combination of VIP and phentolamine is used for erectile dysfunction.

How does VIP work?

VIP binds to the receptors VPAC1 and VPAC2, which it shares with the related PACAP. There it mainly switches on the cAMP pathway. Nerves and immune cells release it. It widens vessels, stimulates glands and dampens inflammatory reactions.

What did the sarcoidosis study show?

20 patients with active sarcoidosis inhaled VIP for 4 weeks. It was safe and well tolerated, lung cells produced less TNF-alpha and the number of regulatory T cells in the lung rose. The study was open and had no placebo group.

Does VIP help in severe COVID-19?

The large TESICO trial with 471 people found no benefit as an infusion, after 90 days 38 versus 36 percent had died. An earlier trial with 196 people missed its main goal. Inhaled, VIP shortened the hospital stay from 10 to 7.8 days in a small study with 80 people.

What does VIP have to do with migraine?

In a study 21 people with migraine received a 2-hour infusion of VIP or placebo. After VIP 71 percent had a migraine attack, after placebo 5 percent. The temporal artery was widened. VIP and its receptors are therefore seen as possible targets for migraine drugs.

Which side effects are known?

Because VIP widens vessels, the regular entry lists a drop in blood pressure, flushing and dizziness. As a long infusion it often triggered attacks in people with migraine. In the large COVID-19 trial serious events by day 5 occurred in 63 versus 56 percent, without a significant difference.

Seotud

Seotud tooted